Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide
- PMID: 8825535
- DOI: 10.1007/BF03011251
Treatment of postoperative nausea and vomiting: comparison of propofol, droperidol and metoclopramide
Abstract
Purpose: To compare the efficacy of propofol in a subhypnotic dose (10 mg iv), droperidol (1.25 mg iv), or metoclopramide (10 mg iv) in the treatment of PONV in the post anaesthesia care unit (PACU).
Methods: In a prospective, randomized, double-blind protocol, over four months, all eligible inpatients and outpatients were asked to give their consent to be included in the study should they suffer PONV in the PACU. They received a standardized general anaesthetic without any prophylactic antiemetic drug. In the recovery room, patients complaining of persistent nausea (lasting more than ten minutes) and/or experiencing at least two episodes of retching or vomiting were given one of the three study drugs. Recurrence of retching or vomiting was recorded for 60 min after administration of the study drug and nausea severity was assessed on a visual analog scale. Patients still complaining of PONV 30 min after administration of the study drug received a rescue medication (dimenhydrinate).
Results: Seventy-eight patients received one of the study drugs. The recurrence of retching or vomiting was higher with propofol (58%) than with droperidol (4%) or metoclopramide (24%) (P < 0.001). More patients who received propofol needed the rescue medication (54%) than those who received droperidol (15%) or metoclopramide (28%) (P < 0.02). No difference was observed in nausea severity.
Conclusion: A subhypnotic dose of propofol (10 mg iv) is less effective than the conventional antiemetic drugs droperidol and metoclopramide for the treatment of PONV in the PACU.
Similar articles
-
Comparison of propofol, droperidol, and metoclopramide for prophylaxis of postoperative nausea and vomiting after breast cancer surgery: a prospective, randomized, double-blind, placebo-controlled study in Japanese patients.Clin Ther. 2008 Nov;30(11):2024-9. doi: 10.1016/j.clinthera.2008.11.011. Clin Ther. 2008. Retraction in: Clin Ther. 2018 Jun;40(6):1048. doi: 10.1016/j.clinthera.2018.04.009. PMID: 19108790 Retracted. Clinical Trial.
-
Granisetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting after thyroidectomy.Laryngoscope. 1999 Apr;109(4):664-7. doi: 10.1097/00005537-199904000-00028. Laryngoscope. 1999. Retraction in: Laryngoscope. 2017 Sep;127(9):E335. doi: 10.1002/lary.26511. PMID: 10201761 Retracted. Clinical Trial.
-
Prevention of postoperative nausea and vomiting in female patients during menstruation: comparison of droperidol, metoclopramide and granisetron.Br J Anaesth. 1998 Feb;80(2):248-9. doi: 10.1093/bja/80.2.248. Br J Anaesth. 1998. Retraction in: Br J Anaesth. 2013 Apr;110(4):669. doi: 10.1093/bja/aet053. PMID: 9602596 Retracted. Clinical Trial.
-
[Prophylaxis of nausea and vomiting in the postoperative phase: relative effectiveness of droperidol and metoclopramide].Anaesthesist. 2011 May;60(5):432-40, 442-5. doi: 10.1007/s00101-010-1825-4. Epub 2010 Dec 12. Anaesthesist. 2011. PMID: 21153527 Review. German.
-
Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review.Yakugaku Zasshi. 2001 Feb;121(2):179-85. doi: 10.1248/yakushi.121.179. Yakugaku Zasshi. 2001. PMID: 11218733
Cited by
-
Prevention and treatment of postoperative nausea and vomiting.Drugs. 2000 Feb;59(2):213-43. doi: 10.2165/00003495-200059020-00005. Drugs. 2000. PMID: 10730546 Review.
-
Treatment of established postoperative nausea and vomiting: a quantitative systematic review.BMC Anesthesiol. 2001;1(1):2. doi: 10.1186/1471-2253-1-2. BMC Anesthesiol. 2001. PMID: 11734064 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical